BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 788448)

  • 1. Four years overall experience with a new low estrogen -- low progestogen oral contraceptive.
    Brat T
    Acta Obstet Gynecol Scand Suppl; 1976; 54():67-70. PubMed ID: 788448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of a multicentre trial of a new low-dose oral contraceptive in Great Britain.
    Bye PG
    Acta Obstet Gynecol Scand Suppl; 1976; 54():61-6. PubMed ID: 788447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary results from a swedish multicenter trial of a new low dose combined oral contraceptive.
    Ingemanson CA; Jägerhorn M; Zizala J; Nilsson B; Zador G
    Acta Obstet Gynecol Scand Suppl; 1976; 54():71-5. PubMed ID: 788449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.
    Gaspard UJ; Deville JL; Dubois M
    Curr Med Res Opin; 1983; 8(6):395-404. PubMed ID: 6406157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new ultra-low-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel.
    Rekers H
    Acta Obstet Gynecol Scand; 1988; 67(2):171-4. PubMed ID: 2972160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 150/30 formulation. Experience in the United Kingdom.
    Guillebaud J
    J Reprod Med; 1983 Jan; 28(1 Suppl):66-70. PubMed ID: 6403702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile of a new low dose combination estrogen and progestogen oral contraceptive: a review of nine clinical studies.
    Woutersz TB
    J Reprod Med; 1975 Sep; 15(3):87-92. PubMed ID: 1214254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 micrograms ethinyl estradiol and 100 micrograms levonorgestrel over six treatment cycles.
    Bannemerschult R; Hanker JP; Wünsch C; Fox P; Albring M; Brill K
    Contraception; 1997 Nov; 56(5):285-90. PubMed ID: 9437556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three and one-half years' experience with a lower-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1976 Jun; 16(6):338-44. PubMed ID: 957360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy, acceptability and metabolic effects of new low dose combined oral contraceptives.
    Bergstein NA
    Acta Obstet Gynecol Scand Suppl; 1976; 54():51-9. PubMed ID: 788446
    [No Abstract]   [Full Text] [Related]  

  • 12. Fertility regulation using "triphasic" administration of ethinyl estradiol and levonorgestrel in comparison with the 30 plus 150 micrograms fixed dose regime.
    Zador G
    Acta Obstet Gynecol Scand Suppl; 1979; 88():43-8. PubMed ID: 393049
    [No Abstract]   [Full Text] [Related]  

  • 13. Two oral contraceptives, efficacy, serum proteins, and lipid metabolism. A comparative multicentre study on a triphasic and a fixed dose combination.
    Cullberg G; Samsioe G; Andersen RF; Bredesgaard P; Andersen NB; Ernerot H; Fanøe E; Fylling P; Haack-Sørensen PE; Klottrup P; Pedersen JH; Sandager T
    Contraception; 1982 Sep; 26(3):229-43. PubMed ID: 6217028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical assessment of a low-oestrogen combined oral contraceptive.
    Bye PG; Elstein M
    Br Med J; 1973 May; 2(5863):389-92. PubMed ID: 4574044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with ethinyl estradiol and d-norgestrel as an oral contraceptive.
    Apelo R; Veloso I
    Fertil Steril; 1975 Mar; 26(3):283-8. PubMed ID: 1116622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical use of combined contraceptive preparations of Hungarian manufacture].
    Farkas M
    Akush Ginekol (Mosk); 1983 Nov; (11):11-4. PubMed ID: 6364870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M; Røde A; Westergaard J
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestogen-only microdose followed by estrogen-progestogen combination, a new approach to oral contraception.
    Russowsky M; Sartoretto JN
    Contraception; 1982 Jul; 26(1):41-9. PubMed ID: 7128133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new low-oestrogen, low-progestogen combined oral contraceptive.
    Woutersz TB
    Curr Med Res Opin; 1974; 2(2):95-100. PubMed ID: 4828628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparison of two oral contraceptives containing 50 mu g. and 30 mu g. ethinyl estradiol.
    Dionne P; Vickerson F
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):281-8. PubMed ID: 4208342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.